Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;31(2):150-157.
doi: 10.1111/pai.13129. Epub 2019 Dec 3.

Economic evaluation of interventions for the treatment of asthma in children: A systematic review

Luca Adél Halmai  1 , Aileen Rae Neilson  2 , Mary Kilonzo  3
Affiliations

Economic evaluation of interventions for the treatment of asthma in children: A systematic review

Luca Adél Halmai et al. Pediatr Allergy Immunol. 2020 Feb.

Abstract

Objectives: This systematic review aimed to identify and critique full economic evaluations (EEs) of childhood asthma treatments with the intention to guide researchers and commissioners of pediatric asthma services toward potentially cost-effective strategies.

Methods: "MEDLINE," "Embase," "EconLit," "NHS EED," and "CEA" databases were searched to identify relevant EEs published between 2005 and May 2017. Quality of included studies was assessed with a published checklist.

Results: Eighteen studies were identified and comprised one cost-benefit analysis, 11 cost-effectiveness analyses, one cost-minimization analysis, and six cost-utility analyses. Treatments included pharmaceutical (n = 11) and non-pharmaceutical (n = 7) interventions. Fourteen studies identified cost-effective strategies. The quality of the studies varied and there were uncertainties due to the methods and relevance of data used.

Conclusion: Good-quality economic evaluation studies of pediatric asthma treatments are lacking. EE of new technologies adapted to local settings is recommended and can result in cost savings.

Keywords: adverse childhood experience; asthma; child; cost-effectiveness; costs and cost analysis; economic evaluation; respiratory tract diseases; systematic review.

PubMed Disclaimer

References

REFERENCES

    1. Mayo Clinic. Mayo Clinic - diseases and conditions. diseases and conditions asthma. 1988-2017. Available at: http://www.mayoclinic.org/diseases-conditions/asthma/basics/definition/c.... Accessed May 14, 2017.
    1. World Health Organisation. Chronic respiratory diseases. 2017. Available at: http://www.who.int/respiratory/asthma/definition/en/. Accessed May 14, 2017.
    1. Global Initiative for Asthma. . Global strategy for asthma management and prevention. Global strategy for asthma management and prevention. 2016. ; www.ginasthma.orghttp://ginasthma.org/wp-content/uploads/2016/04/GINA-2016-main-report_tracked.pdf. Accessed May 11, 2017.
    1. Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ. 2007;56(8):1-54.
    1. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143-178.

Publication types

LinkOut - more resources